Global Patent Index - EP 4337631 A1

EP 4337631 A1 20240320 - DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY

Title (en)

DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY

Title (de)

DERIVATE VON CANNABIDIOL-C4 ZUR BEHANDLUNG VON EPILEPSIE

Title (fr)

DÉRIVÉS DE CANNABIDIOL-C4 POUR LE TRAITEMENT DE L'ÉPILEPSIE

Publication

EP 4337631 A1 20240320 (EN)

Application

EP 22724857 A 20220511

Priority

  • GB 202106788 A 20210512
  • GB 2022051199 W 20220511

Abstract (en)

[origin: WO2022238700A1] The present invention relates to compounds that are pharmaceutically active and methods of preparation thereof. The compounds of the invention are 7-hydroxy-cannabidol-C4 (7-OH-CBD-C4) and 7-carboxy-cannabidiol-C4 (7-COOH-CBD-C4). The compounds of the invention are related to cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of the compounds of the invention.

IPC 8 full level

C07C 39/23 (2006.01); A61K 31/047 (2006.01); A61P 25/08 (2006.01)

CPC (source: EP KR)

A61K 31/658 (2023.05 - KR); A61P 25/08 (2018.01 - EP KR); C07C 37/50 (2013.01 - KR); C07C 39/23 (2013.01 - EP KR); C07C 51/38 (2013.01 - KR); C07C 62/32 (2013.01 - KR); A61K 2300/00 (2013.01 - KR); C07B 2200/07 (2013.01 - EP KR); C07C 2601/16 (2017.05 - EP)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022238700 A1 20221117; AU 2022273928 A1 20231109; CA 3216179 A1 20221117; CN 117295706 A 20231226; EP 4337631 A1 20240320; JP 2024518520 A 20240501; KR 20240007185 A 20240116; MX 2023013338 A 20231127

DOCDB simple family (application)

GB 2022051199 W 20220511; AU 2022273928 A 20220511; CA 3216179 A 20220511; CN 202280033614 A 20220511; EP 22724857 A 20220511; JP 2023569986 A 20220511; KR 20237041272 A 20220511; MX 2023013338 A 20220511